Integrative Cancer Solutions with Dr. Karlfeldt

Amanda King ND on Metabolic Drugs for Cancer: Repurposed Meds, Ketogenic Therapy, and Personalized Integrative Oncology

Integrative Cancer Solutions with Dr. Karlfeldt

Show Notes

Amanda King ND is a nutritional therapist, naturopathic practitioner, and author of Metabolic Drugs for Cancer (co-written with Dr. Hari Kuhan). She also writes The Metabolic Nutritionist on Substack—followed by 30,000+ subscribers—where she breaks down off-label oncology drugs, supplements, and metabolic approaches to cancer care in clear, practical language. In this episode, Dr. King joins Dr. Michael Karlfeldt to explain why “cancer is a disease of metabolism” is more than a slogan—and how understanding metabolic weaknesses can empower smarter, more personalized integrative strategies. You’ll hear how repurposed medications can target cancer’s metabolic pathways (glucose, mitochondria, inflammatory signaling, and more), and why personalization matters more than internet protocols. Amanda and Dr. Karlfeldt discuss the Care Oncology “METRICS” drug set (including metformin, statins, doxycycline, and mebendazole), plus additional tools like ivermectin, fenbendazole, DCA, 2-DG, anti-inflammatories (aspirin/COX pathways), histamine blockers (cimetidine), and even PDE5 inhibitors like sildenafil/tadalafil—along with real cautions around dosing, contraindications, and interactions (including potential conflicts with immunotherapy). The conversation also ties metabolic therapy to the “press–pulse” concept and terrain-based care: ketogenic nutrition, inflammation reduction, oxygenation, and lifestyle foundations that strengthen the body while making cancer more vulnerable. Whether you’re a patient, caregiver, or practitioner, this episode offers a grounded roadmap for thinking about integrative oncology without guesswork—using a “test, assess, address” mindset to build a strategy that evolves with labs, symptoms, treatment phases, and the individual. Key Topics Covered Why cancer metabolism (not just genetics) is a key lever in integrative oncology What repurposed/off-label drugs can target: glucose pathways, mitochondria, signaling pathways (e.g., EGFR/AKT/mTOR) Why one-size-fits-all protocols are risky—and how to personalize using “test, assess, address” The Care Oncology/METRICS drug set and when it may (or may not) fit Safety and dosing concerns with high-dose ivermectin/fenbendazole and DIY internet protocols When metformin vs berberine may be appropriate—and why they can sometimes be combined Doxycycline: potential synergy (e.g., with IV vitamin C) vs contraindications (including immunotherapy concerns) Anti-inflammatory strategy: COX pathways, aspirin vs selective COX-2 approaches, plus natural options “Press–pulse” metabolic strategy and why protocols should evolve over time Other emerging tools discussed: DCA, 2-DG, cimetidine, itraconazole, PDE5 inhibitors (Viagra/Cialis)

____________________________________ RESOURCES FROM DR. KARLFELDT: 📖 A Better Way to Treat Cancer: A Comprehensive Guide to Understanding, Preventing and Most Effectively Treating Our Biggest Health Threat Get it on Amazon: https://a.co/d/0iC8bFxy 📖 Unleashing 10X Power: A Revolutionary Approach to Conquering Cancer Get it here: store.thekarlfeldtcenter.com/products/unleashing-10x-power Price: $24.99 | Use code CANCERPODCAST1 for 100% off 📖 Healing Within: Unraveling the Emotional Roots of Cancer Get it here: store.thekarlfeldtcenter.com/products/healing-within Price: $24.99 | Use code CANCERPODCAST2 for 100% off ____________________________________ WORK WITH DR. KARLFELDT: To learn more about cutting-edge integrative cancer therapies at The Karlfeldt Center or to schedule a free 15-minute consultation, visit us at: 🌐 TheKarlfeldtCenter.com 📞 208-338-8902 📧 [email protected] ____________________________________ CONNECT WITH DR. KARLFELDT: Instagram: instagram.com/thekarlfeldtcenter Facebook: facebook.com/thekarlfeldtcenter ____________________________________ MORE PODCASTS FROM DR. KARLFELDT: 🎙 The Dr. K Show — Integrative medicine, functional medicine, biohacking, and longevity for optimizing health and performance. 🎙 Integrative Lyme Solutions

More from Integrative Cancer Solutions with Dr. Karlfeldt

Oct 21, 2026

What if a breast cancer diagnosis is rarely the emergency it feels like, and the time you take next matters most?

Oct 14, 2026

Which peptides belong in a cancer protocol, and which ones should wait?

Oct 7, 2026

What happens when the surgeon who has spent his career saving other people's lives finally has to save his own? In this episode of Integrative Cancer Solutions, Dr. K sits down with Dr. James C. Wittig, a nationally recognized orthopedic oncologist and sarcoma surgeon and the Founder and CEO of Mandala Medical Group, with roughly 10,000 procedures behind him. He explains why sarcoma in kids and teens so often gets dismissed as a sports injury or growing pains, and how limb-sparing surgery became the standard for most patients. Then he gets personal: thirty years of five-hour nights and eighty-hour weeks that ended in kidney failure and three stents. That experience is why he now brings hypnosis, meditation, neurofeedback and root cause testing like fasting insulin into cancer care. If you or someone you love is facing cancer, this conversation shows what whole-person care can look like from a surgeon who has been on both sides of it. Key Takeaways: Why sarcoma in children and teens gets missed as a sports injury or growing pains How chemotherapy response predicts osteosarcoma survival A sarcoma surgeon's wake-up call: 80-hour weeks, kidney failure and three stents Hypnosis, meditation and neurofeedback for stress and immune health during cancer treatment Fasting insulin, gut health and sugar as root causes in cancer care Schedule a Free 15-Min Cancer/Lyme Consultation at The Karlfeldt Center: 208-338-8902

Sep 30, 2026

What if the last piece of your cancer won't go away because it isn't physical at all? In this episode of Integrative Cancer Solutions, Dr. K sits down with Dr. Dana Flavin, a pharmacologist, toxicologist, biochemist and physician with 58 semesters of training behind her and more than 30 years of treating cancer patients around the world. Dana never set out to treat anyone. That changed in 1992, when friends in Ireland asked her to help a woman with advanced cervical cancer, no money and no insurance. Six months later the tumor was gone, and Dana has spent the decades since mapping how foods, nutrients, repurposed drugs and emotions each act on cancer biochemistry. She explains why a single-target drug so often stops working, and how shiitake and maitake mushrooms knock down the same immune-suppressing cells as cimetidine. She covers why a low-methionine, low-sugar, plant-based diet matters, and shares a stage 4 prostate cancer case where PSA dropped from 5,000 to 24.4 in 10 weeks. She also tells the story of a breast cancer patient whose last bit of tumor only cleared after she learned to love herself. If you or someone you love is fighting cancer, or working hard to keep it from coming back, this conversation gives you a lot to take to your care team. Key Takeaways: Why combination cancer therapy works when single-target drugs lead to resistance, from a colon cancer case with liver, lung and lymph metastases How shiitake and maitake mushrooms and cimetidine lower myeloid-derived suppressor cells so the immune system can recover A plant-based, low-methionine, low-sugar diet for cancer, plus cherries, raspberries and organic food Off-label drugs in a stage 4 prostate cancer case: PSA from 5,000 to 24.4 in 10 weeks with itraconazole, ivermectin, mebendazole and low dose naltrexone Emotional healing, forgiveness and staying in remission, and why unresolved hurt can bring cancer back

Sep 16, 2026

What if a blue-green algae could help your cells fight cancer the same way your own immune system does? In this episode of Integrative Cancer Solutions, Dr. K talks with Catharine Arnston, PhD, founder of ENERGYbits and author of the upcoming book Love Your Health to Bits with Algae. Catharine has spent years researching spirulina and chlorella, and she walks through why she sees cancer as a metabolic disease, one driven by damaged mitochondria, acidic cells, and the glucose that feeds tumor growth, a process known as the Warburg effect. She breaks down how superoxide dismutase protects your mitochondria from free radical damage, how chlorella clears the toxins that block your cell receptors, and how the blue pigment in spirulina called phycocyanin can trigger cancer cells to self-destruct while leaving healthy cells alone. If you or someone you love is trying to prevent, treat, or recover from cancer, this conversation gives you nutritional tools you can start using today. Key Takeaways: Why cancer is increasingly understood as a metabolic disease driven by the Warburg effect and glucose-fueled cell growth How spirulina's superoxide dismutase (SOD) content protects mitochondria from free radical damage as natural SOD levels decline with age Chlorella's detoxifying effect on cell receptors, and why clearing out cell-blocking toxins matters for nutrient absorption Phycocyanin, the blue pigment unique to spirulina, and its documented anti-angiogenesis effect and role in triggering apoptosis in cancer cells Why cutting simple sugars and carbs and increasing movement lowers the glucose available to feed cancer cells, tracked through the glucose ketone index (GKI)

See all episodes →